CPHI vs CRON

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

CPHI

59.3
AI Score
VS
CPHI Wins

CRON

50.5
AI Score

Investment Advisor Scores

CPHI

59score
Recommendation
STRONG BUY

CRON

51score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CPHI CRON Winner
Forward P/E 1.5581 22.3714 CPHI
PEG Ratio 0.1558 0 Tie
Revenue Growth -7.5% 74.6% CRON
Earnings Growth 0.0% -41.0% CPHI
Tradestie Score 59.3/100 50.5/100 CPHI
Profit Margin -114.3% 28.0% CRON
Beta 1.00 1.00 Tie
AI Recommendation STRONG BUY HOLD CPHI

Relative Price Performance (Last 90 Days)

CPHI 1M: -27.7% · 3M: -50.2% CRON 1M: +7.8% · 3M: +9.2%

Current Technical Phase

CPHI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -18.9%), weak momentum, RSI 35

RSI (14): 34.6 · Price: $0.54

CRON

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (1.9% over 20 days), RSI 54

RSI (14): 53.8 · Price: $3.45

Fundamentals Snapshot

Metric CPHI CRON
Market Cap — —
Forward P/E 1.6 13.3
Trailing P/E — 21.3
Revenue (TTM) — —
Revenue Growth -0.1% 0.7%
Gross Margin 0.1% 0.5%
Operating Margin -1.5% 0.1%
EPS -0.42 0.16
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, CPHI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.